Deep characterization of paired chromatin and transcriptomes in four immune cell types from multiple sclerosis patients.
Sunjay Jude FernandesMatilda EricssonMohsen KhademiMaja JagodicTomas OlssonDavid Gomez-CabreroIngrid KockumJesper TegnérPublished in: Epigenomics (2021)
Background: The putative involvement of chromatin states in multiple sclerosis (MS) is thus far unclear. Here we determined the association of chromatin-accessibility with concurrent genetic, epigenetic and transcriptional events. Material & methods: We generated paired assay for transposase-accessible chromatin sequencing and RNA-sequencing profiles from sorted blood immune CD4+ and CD8+ T cells, CD14+ monocytes and CD19+ B cells from healthy controls (HCs) and MS patients. Results: We identified differentially accessible regions between MS patients and HCs, primarily in CD4+ and CD19+. CD4+ regions were enriched for MS-associated single nucleotide polymorphisms and differentially methylated loci. In the vicinity of differentially accessible regions of CD4+ cells, 42 differentially expressed genes were identified. The top two dysregulated genes identified in this multilayer analysis were CCDC114 and SERTAD1. Conclusion: These findings provide new insight into the primary role of CD4+ and CD19+ cells in MS.
Keyphrases
- multiple sclerosis
- end stage renal disease
- genome wide
- mass spectrometry
- chronic kidney disease
- ejection fraction
- newly diagnosed
- ms ms
- dna damage
- single cell
- peritoneal dialysis
- dna methylation
- induced apoptosis
- squamous cell carcinoma
- patient reported outcomes
- high throughput
- immune response
- cell proliferation
- genome wide association study